A qualitative stage-gating framework based on concordant evidence of target-site exposure, target-cell activity, reproducible product quality, acceptable repeat-dose performance, and a testable biomarker strategy is proposed that supports formulation selection, cross-platform comparison, and translational prioritizatio...
Bao-Dan Xu, Dan Wei, Kai-Shan Tao et al.· Pharmaceutics· 0 citations